Voclosporin-based, triple-immunosuppressive therapy vs high-dose glucocorticoid-based dual-immunotherapy for lupus nephritis: a propensity analysis

被引：0
|
作者：
Yap, Ernie [1 ]
Askanase, Anca [2 ]
Kalunian, Kenneth [3 ]
Dall'era, Maria [4 ]
Hodge, Lucy [1 ]
Truman, Matt [1 ]
Solomons, Neil [5 ]
机构：
[1] Aurinia Pharmaceut Inc, Edmonton, AB, Canada
[2] Columbia Univ, Irving Med Ctr, New York, NY USA
[3] Univ Calif San Diego, San Diego, CA USA
[4] Univ Calif San Francisco, San Francisco, CA USA
[5] Neil Solomons Consulting, Toronto, ON, Canada
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
468
引用
收藏
页码：I245 / I247
页数：3
相关论文
共 11 条
  • [1] Voclosporin-based, triple-immunosuppressive therapy vs high-dose glucocorticoid-based dual-immunotherapy for lupus nephritis: a propensity analysis
    Yap, Ernie
    Askanase, Anca
    Kalunian, Kenneth
    Dall'era, Maria
    Hodge, Lucy
    Truman, Matt
    Solomons, Neil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [2] Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS
    Dall'Era, Maria
    Kalunian, Kenneth
    Solomons, Neil
    Truman, Matt
    Hodge, Lucy S.
    Yap, Ernie
    Askanase, Anca D.
    LUPUS SCIENCE & MEDICINE, 2024, 11 (02):
  • [3] A PROPENSITY ANALYSIS OF AURA-LV PLUS AURORA 1 VS ALMS TO COMPARE A VOCLOSPORIN-BASED, TRIPLE IMMUNOTHERAPY REGIMEN TO HIGH -DOSE GLUCOCORTICOID-BASED IMMUNOSUPPRESSIVE THERAPY
    Kalunian, Kenneth
    Askanase, Anca
    Dall'Era, Maria
    Solomons, Neil
    Truman, Matt
    Hodge, Lucy S.
    Yap, Ernie
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S116 - S117
  • [4] Comparison of Dual-immunosuppressive Therapy with a Voclosporin-based, Triple-immunosuppressive Regimen for Lupus Nephritis in the ALMS and AURORA 1 Studies
    Dall'Era, Maria
    Yap, Ernie
    Truman, Matt
    Hodge, Lucy
    Solomons, Neil
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1571 - 1573
  • [5] 14-day high-dose dual therapy versus 14-day clarithromycin based standard triple therapy: A promising alternative therapy?
    Leow, Alex Hwong-Ruey
    Goh, Khean Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 69 - 69
  • [6] Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin
    Miehlke, S.
    Hansky, K.
    Schneider-Brachert, W.
    Kirsch, C.
    Morgner, A.
    Madisch, A.
    Kuhlisch, E.
    Baestlein, E.
    Jacobs, E.
    Bayerdoerffer, E.
    Lehn, N.
    Stolte, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (02) : 395 - 403
  • [7] Low-dose or high-dose amoxicillin in vonoprazan-based dual therapy for Helicobacter pylori eradication? A systematic review and meta-analysis
    Ju, Kun-Ping
    Kong, Qing-Zhou
    Li, Yue-Yue
    Li, Yan-Qing
    HELICOBACTER, 2024, 29 (01)
  • [8] Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen - An open-label, randomized trial
    Jiang, Xin
    Deng, Bin
    Gao, Xuefeng
    Zhang, Yun
    Li, Guangyao
    Li, Guiqing
    She, Qiang
    Ding, Yanbing
    OPEN MEDICINE, 2023, 18 (01):
  • [9] Treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin -: prospective, randomized trial comparing a 7-day rifabutin-based triple therapy with a high-dose omeprazole/amoxicillin dual therapy (interims analysis)
    Bayerdörffer, E
    Hansky, K
    Schneider-Brachert, W
    Kirsch, C
    Kroettinger, A
    Bästlein, E
    Haferland, C
    Buchner, M
    Heptner, G
    Stolte, M
    Jacobs, E
    Lehn, N
    GUT, 2002, 51 : A91 - A92
  • [10] 14-day high-dose dual therapy is equally as good as 14-day clarithromycin based standard triple therapy in first line H. pylori eradication treatment
    Leow, Alex Hwong-Ruey
    Goh, Khean-Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 363 - 363
12